Shaoda Ren
Overview
Explore the profile of Shaoda Ren including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
220
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu M, Li N, Wang Z, Wang S, Ren S, Li X
RSC Med Chem
. 2024 Sep;
PMID: 39246745
Accumulating evidence suggests that the root of drug chemoresistance in ovarian cancer is tightly associated with subpopulations of cancer stem cells (CSCs), whose activation is largely associated with signal transducer...
2.
Li N, Li C, Zhang J, Jiang Q, Wang Z, Nie S, et al.
Chem Biol Interact
. 2022 Sep;
366:110172.
PMID: 36096161
The hallmark of ovarian cancer is its high mortality rate attributed to the existence of cancer stem cells (CSCs) subpopulations which result in therapy recurrence and metastasis. A series of...
3.
Li X, Liu Y, Wang N, Liu Y, Wang S, Wang H, et al.
RSC Adv
. 2022 May;
9(47):27294-27304.
PMID: 35529208
Despite advances in ovarian cancer treatment, the five-year overall survival rate is less than 30% with the presence of cancer stem cells (CSCs). To develop CSC-targeting therapy, a series of...
4.
Zhang Y, Ding J, Ren S, Wang W, Yang Y, Li S, et al.
Stem Cell Res Ther
. 2020 May;
11(1):207.
PMID: 32460839
The novel coronavirus disease 2019 (COVID-19) has grown to be a global public health emergency since patients were first detected in Wuhan, China. Thus far, no specific drugs or vaccines...
5.
Li X, Dong Y, Yin H, Qi Z, Wang D, Ren S
Immunol Lett
. 2020 Mar;
222:49-57.
PMID: 32199868
Mesenchymal stem cells (MSCs) are one of the attractive candidates in regenerative medicine of many clinical applications because of their low immunogenicity and immunomodulatory property. Our previous studies provided that...
6.
Synthesis and biological evaluation of celastrol derivatives as anti-ovarian cancer stem cell agents
Li X, Ding J, Li N, Liu W, Ding F, Zheng H, et al.
Eur J Med Chem
. 2019 Jul;
179:667-679.
PMID: 31279299
Ovarian cancer is associated with a high percentage of recurrence of tumors and resistance to chemotherapy. Cancer stem cells (CSCs) are responsible for cancer progression, tumor recurrence, metastasis, and chemoresistance....
7.
Li X, Wang H, Ding J, Nie S, Wang L, Zhang L, et al.
Eur J Pharmacol
. 2018 Nov;
842:146-156.
PMID: 30389635
Ovarian cancer is one of the most serious diseases worldwide and the fifth-most common cancer among women. Celastrol, extracted from Thunder God Vine, exerts anti-cancer effects on various cancers; however,...
8.
Liu X, Ren S, Ge C, Cheng K, Li X, Zhao R
Stem Cells Dev
. 2018 Apr;
27(8):556-565.
PMID: 29649410
Mesenchymal stem cells (MSCs) have a superior immunomodulatory capacity compared to other cells of the immune system, and they hold great promise for treating various immune disorders. However, their regulatory...
9.
Dong Y, Li T, Li Y, Ren S, Fan J, Weng X
Mol Med Rep
. 2017 Oct;
16(6):9331-9336.
PMID: 29039554
The mechanism of steroid-associated femoral head necrosis remains unclear. The present study investigated the role of microRNA-23a-3p (miR-23a-3p) in the incidence of osteonecrosis in a rat model. An miR-23a-3p mimic,...
10.
Liu Y, Mu Y, Zhang A, Ren S, Wang W, Xie J, et al.
Onco Targets Ther
. 2017 Apr;
10:1897-1908.
PMID: 28408841
Background: Immunotherapy based on cytokine-induced killer cells or combination of dendritic cells and cytokine-induced killer cells (CIK/DC-CIK) showed promising clinical outcomes for treating esophageal cancer (EC). However, the clinical benefit...